rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 
Rediff.com  » Business » Sun Pharma gets USFDA nod for anti-cancer injection

Sun Pharma gets USFDA nod for anti-cancer injection

February 05, 2013 13:46 IST

Sun Pharmaceutical Industries on Tuesday said it has received US health regulator's approval to market generic version of Doxil injection, used in treating ovarian cancer in the American market.

The Mumbai-headquartered firm, in a statement, said its subsidiary has received approval from US food and Drug Administration (USFDA) for its Doxorubicin HCl Liposome Injection.

"This generic Doxorubicin HCl Liposome injection USP, 2 mg/ml is therapeutically equivalent to Doxil Liposome Injection, 2 mg/ml of Janssen Research and Development, LLC," the company said.

Doxorubicin HCl liposome injection is used to treat patients with ovarian cancer that has progressed or recurred after platinum-based chemotherapy.

© Copyright 2014 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.